ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

23,775Medicare Part D Prescriptions Filled, Including Refills

Rank: 52 out of 2888

$2.37M Total Retail Price of All Prescriptions

Rank: 16 out of 2888

667 Patients Receiving at Least One Drug in Part D
80%Patients 65 Years and Older
96% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Texas
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

16% of this provider’s 667 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

3% of this provider’s 20,248 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

34% of this provider’s prescriptions were for brand-name drugs, compared to an average of 27%.

Prescription Price

$100 was the average price of a prescription from this provider, compared to $67 among peers.

Prescriptions per Patient

36 is the average number of prescriptions (including refills) per patient, compared to an average of 19.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Texas
LEVOTHYROXINE SODIUM 1,059 904 1 1
OMEPRAZOLE 705 590 2 7
FUROSEMIDE 551 496 3 6
NEXIUM 530 471 4 19
POTASSIUM CHLORIDE 525 470 5 14
METOPROLOL SUCCINATE 462 377 6 11
SIMVASTATIN 432 377 7 2
ZOSTAVAX 421 357 8 221
MELOXICAM 421 390 8 31
CILOSTAZOL 382 328 10 165
ALENDRONATE SODIUM 357 322 11 23
AMLODIPINE BESYLATE 356 342 12 5
GLYBURIDE-METFORMIN HCL 353 284 R 13 64
CIPROFLOXACIN HCL 344 292 14 47
NAMENDA 336 318 15 34
GABAPENTIN 331 262 16 13
METFORMIN HCL 316 248 17 8
JANUVIA 313 284 18 48
AMOX TR-POTASSIUM CLAVULANATE 303 252 19 112
LISINOPRIL 291 235 20 3
HYDROCODONE-ACETAMINOPHEN 265 159 S3 21 4
LOSARTAN POTASSIUM 256 226 22 18
SERTRALINE HCL 250 201 23 27
CRESTOR 242 189 24 20
ZOLPIDEM TARTRATE 240 183 25 17
TRAMADOL HCL 240 199 25 16
TAMSULOSIN HCL 240 216 25 29
MUPIROCIN 227 194 28 184
CLOPIDOGREL 224 191 29 30
DONEPEZIL HCL 221 210 30 26
ATORVASTATIN CALCIUM 219 197 31 9
VOLTAREN 212 179 32 157
CREON 210 192 33 346
ISOSORBIDE MONONITRATE ER 209 185 34 51
METOPROLOL TARTRATE 196 170 35 10
DIOVAN 185 177 36 35
POLYETHYLENE GLYCOL 3350 184 153 37 93
SINGULAIR 183 162 38 85
HYDROCHLOROTHIAZIDE 182 160 39 15
PREDNISONE 181 154 40 42
PRAVASTATIN SODIUM 174 141 41 12
DIGOXIN 160 144 42 55
FLUTICASONE PROPIONATE 159 141 43 32
PLAVIX 150 133 44 40
RAMIPRIL 149 114 45 73
LYRICA 145 115 46 69
BYSTOLIC 141 120 47 99
ESCITALOPRAM OXALATE 140 113 48 62
FENOFIBRATE 129 101 49 65
ATENOLOL 121 110 50 25
IBUPROFEN 118 81 51 87
CLOTRIMAZOLE-BETAMETHASONE 116 101 52 136
INSULIN SYRINGE 116 99 52 86
CLOBETASOL PROPIONATE 114 92 54 298
AZITHROMYCIN 110 91 55 38
CARVEDILOL 109 90 56 21
NITROFURANTOIN 108 104 57 241
WARFARIN SODIUM 108 101 57 22
LUNESTA 103 85 59 301
LOSARTAN-HYDROCHLOROTHIAZIDE 103 89 59 46
TRAMADOL HCL-ACETAMINOPHEN 102 83 61 95
DIOVAN HCT 100 90 62 61
PEN NEEDLE 100 81 62 110
PRIMIDONE 98 86 64 287
LIDODERM 98 80 64 105
JANUMET 97 87 66 131
CEFADROXIL 96 80 67 418
AMLODIPINE BESYLATE-BENAZEPRIL 95 75 68 67
TRICOR 94 74 69 91
LANTUS 94 75 69 45
MONTELUKAST SODIUM 93 82 71 153
ACETIC ACID 92 83 10 72 494
LACTULOSE 91 83 73 111
AMMONIUM LACTATE 90 78 74 360
EXELON 89 89 75 106
ACTOS 87 67 76 108
METRONIDAZOLE 82 67 77 256
BACLOFEN 82 64 77 121
CHLORHEXIDINE GLUCONATE 82 68 77 289
MOMETASONE FUROATE 80 73 80 268
LIDOCAINE HCL 80 71 80 297
ENALAPRIL MALEATE 79 67 82 49
METHSCOPOLAMINE BROMIDE 76 70 83 507
FLUCONAZOLE 74 62 84 199
TRIAMTERENE-HCTZ 73 59 85 63
SULFAMETHOXAZOLE-TRIMETHOPRIM 73 69 85 88
NASONEX 69 62 87 168
ALLOPURINOL 69 51 87 37
LIPITOR 68 60 89 78
EVISTA 68 66 89 125
DICYCLOMINE HCL 65 60 91 224
IBANDRONATE SODIUM 65 54 91 272
GLIMEPIRIDE 62 48 93 36
CYMBALTA 62 45 93 44
BONIVA 61 50 95 319
AMITIZA 61 47 95 296
PHENYTOIN SODIUM EXTENDED 61 50 95 128
VICTOZA 3-PAK 61 51 95 331
LOVAZA 60 46 99 97
ADVAIR DISKUS 60 56 99 60
CLONIDINE HCL 59 48 101 39
PROMETHAZINE HCL 59 43 R 101 96
NITROGLYCERIN PATCH 59 45 101 183
NAPROXEN 58 46 104 80
MECLIZINE HCL 57 44 105 122
TRILIPIX 55 49 106 160
LEVEMIR FLEXPEN 55 48 106 156
NYSTATIN 55 51 106 178
SPIRONOLACTONE 54 37 109 70
LEXAPRO 53 43 110 198
MEGACE ES 52 51 R 111 310
CYCLOBENZAPRINE HCL 52 38 R 111 68
ENABLEX 52 52 111 269
CELEBREX 52 46 111 89
ZETIA 52 43 111 81
FORTEO 51 51 116 292
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 30, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.